Skip to main content
FTRE
NASDAQ Industrial Applications And Services

Fortrea Reinstates CFO Jason Knoblauch After Settling Non-Compete Lawsuit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$16.79
Mkt Cap
$1.597B
52W Low
$8.305
52W High
$21.39
52W Position info
102% above low
Off High info
22% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $8.305.

Summary

Fortrea reinstated Jason Knoblauch as CFO after settling the non-compete lawsuit that had sidelined him since July. Interim CFO David Smith returns to his board-only role.


Key Events · Executive and Board Changes · FTRE

  • CFO Reinstated After Settlement

    Jason Knoblauch reinstated as CFO and principal financial officer effective September 9, 2026, following a settlement and mutual release with his former employer.

  • Legal Cloud Lifted

    The Delaware Court of Chancery temporary restraining order from July 25, 2026, is resolved via settlement, ending the restrictive covenant lawsuit against Knoblauch and Fortrea.

  • Interim CFO Steps Down

    David Smith stepped down from the Interim CFO position but remains a member of the Board of Directors.

  • Compensation Unchanged

    Knoblauch continues to receive the same compensation package previously disclosed in the June 26, 2026 Form 8-K.


Analysis · FTRE · Industrial Applications And Services

Fortrea's CFO saga reaches a resolution. Jason Knoblauch, sidelined since July 25 by a Delaware court order over restrictive covenant violations, is back as CFO and principal financial officer effective September 9. The company, Knoblauch, and his former employer entered a settlement and mutual release, clearing the legal cloud. Interim CFO David Smith steps down but stays on the board. This ends a period of finance leadership instability that began with the June CFO transition and included a CAO resignation and a court order — a governance overhang now removed.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FTRE was trading at $16.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $8.31 to $21.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Oct 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.14
Real-time Price: $19.81 info
Change: -$3.33 (-14%) info
Market Cap: $1.913B info
FTRE
Oct 29, 2026, 6:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.77
Real-time Price: $19.81 info
Change: -$5.96 (-23%) info
Market Cap: $1.913B info
FTRE
Oct 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.80
Real-time Price: $19.81 info
Change: -$5.99 (-23%) info
Market Cap: $1.913B info
FTRE
Sep 10, 2026, 8:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $19.81 info
Change: +$3.02 (+18%) info
Market Cap: $1.913B info
FTRE
Sep 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.72
Real-time Price: $19.81 info
Change: +$2.09 (+12%) info
Market Cap: $1.913B info